CLLS
Cellectis

2,600
Mkt Cap
$274.11M
Volume
26,605.00
52W High
$5.48
52W Low
$1.10
PE Ratio
-11.37
CLLS Fundamentals
Price
$3.79
Prev Close
$3.99
Open
$3.90
50D MA
$4.54
Beta
1.10
Avg. Volume
113,290.73
EPS (Annual)
-$0.4052
P/B
3.78
Rev/Employee
$186,629.20
Loading...
Loading...
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
222

Frequently Asked Questions

What is Market Cap of Cellectis - ADR?
What is the 52-week high for Cellectis - ADR?
What is the 52-week low for Cellectis - ADR?
What is Cellectis - ADR stock price today?
What was Cellectis - ADR stock price yesterday?
What is the PE ratio of Cellectis - ADR?
What is the Price-to-Book ratio of Cellectis - ADR?
What is the 50-day moving average of Cellectis - ADR?
How many employess does Cellectis - ADR has?

Latest CLLS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.